Cordero L, Sananes M, Ayers L W
Department of Pediatrics, The Ohio State University Medical Center, Columbus 43210-1228, USA.
Infect Control Hosp Epidemiol. 1999 Apr;20(4):242-6. doi: 10.1086/501619.
To assess the prevalence of gram-positive coccal (GPC), gram-negative bacillary (GNB), and fungal blood-stream infections (BSIs) during a 12-year period in which a consistent antibiotic treatment protocol was in place; to evaluate the efficacy of these antibiotic policies in relation to treatment, to the emergence of bacterial or fungal resistance, and to the occurrence of infection outbreaks or epidemics.
Case series.
Demographic, clinical, and bacteriological information from 363 infants born during 1986 through 1991 and 1992 through 1997 who developed 433 blood-culture-proven BSIs was analyzed. Early-onset BSIs were defined as those infections discovered within 48 hours of birth, and late-onset BSIs as those that occurred thereafter. Suspected early-onset BSIs were treated with ampicillin and gentamicin, and suspected late-onset BSIs with vancomycin and gentamicin. Antibiotics were changed on the basis of organism antimicrobial susceptibility.
Early-onset BSIs were noted in 52 of 21,336 live births and 40 of 20,402 live births during 1986 through 1991 and 1992 through 1997, respectively. GPC (83% due to group B streptococcus [GBS]) accounted for approximately one half of early-onset BSI cases and GNB (68% Enterobacteriaceae) for the remainder. Early-onset GBS declined from 24 to 11 cases (P=.04) and late-onset BSI increased from 111 to 230 cases (P<.01) from the first to the last study period. Sixty-eight percent of late-onset BSIs were due to GPC (primarily coagulase-negative Staphylococcus), 18% to GNB, and 14% to fungus. Over the study period, Escherichia coli, Klebsiella pneumoniae, Enterobacter cloacae, and Pseudomonas aeruginosa isolated from the newborn intensivecare unit (unlike those strains from other hospital units) remained fully susceptible to ceftazidime and gentamicin. Although the hospitalwide prevalence of methicillin-resistant Staphylococcus aureus increased, all 17 newborn BSI cases were due to methicillin-sensitive strains. Prevalence of methicillin-resistant coagulase-negative Staphylococcus increased, although all strains remained vancomycin-susceptible, as did the 16 Enterococcus faecalis isolates. All fungi recovered (from 48 patients) were susceptible to amphotericin.
We observed a decrease in the prevalence of early-onset BSIs due to GBS and an increase in late-onset BSIs due to GPC, GNB, and fungi. The combination of ampicillin and gentamicin for suspected early-onset BSIs and vancomycin and gentamicin for late-onset BSIs has been successful for treatment of individual patients without the occurrence of infection outbreaks or the emergence of resistance. Controlled antibiotic programs and periodic evaluations based on individual unit and not on hospitalwide antibiograms are advisable.
评估在实施一致的抗生素治疗方案的12年期间革兰氏阳性球菌(GPC)、革兰氏阴性杆菌(GNB)和真菌血流感染(BSI)的患病率;评估这些抗生素策略在治疗、细菌或真菌耐药性出现以及感染暴发或流行发生方面的效果。
病例系列研究。
分析了1986年至1991年以及1992年至1997年期间出生的363例婴儿发生的433例血培养证实的BSI的人口统计学、临床和细菌学信息。早发性BSI定义为出生后48小时内发现的感染,迟发性BSI定义为之后发生的感染。疑似早发性BSI用氨苄西林和庆大霉素治疗,疑似迟发性BSI用万古霉素和庆大霉素治疗。根据微生物药敏情况更换抗生素。
1986年至1991年以及1992年至1997年期间,分别在21336例活产中的52例和20402例活产中的40例中发现早发性BSI。GPC(83%由B组链球菌[GBS]引起)约占早发性BSI病例的一半,其余为GNB(68%为肠杆菌科)。从第一个研究期到最后一个研究期,早发性GBS从24例降至11例(P=0.04),迟发性BSI从111例增至到230例(P<0.01)。68%的迟发性BSI由GPC(主要是凝固酶阴性葡萄球菌)引起,18%由GNB引起,14%由真菌引起。在研究期间,从新生儿重症监护病房分离出的大肠埃希菌、肺炎克雷伯菌、阴沟肠杆菌和铜绿假单胞菌(与其他医院科室分离的菌株不同)对头孢他啶和庆大霉素仍完全敏感。尽管全院耐甲氧西林金黄色葡萄球菌的患病率有所增加,但17例新生儿BSI病例均由甲氧西林敏感菌株引起。耐甲氧西林凝固酶阴性葡萄球菌的患病率增加,尽管所有菌株对万古霉素仍敏感,16株粪肠球菌分离株也是如此。所有分离出的真菌(来自48例患者)对两性霉素敏感。
我们观察到由GBS引起的早发性BSI患病率下降,由GPC、GNB和真菌引起的迟发性BSI患病率增加。对于疑似早发性BSI使用氨苄西林和庆大霉素联合治疗,对于迟发性BSI使用万古霉素和庆大霉素联合治疗,在治疗个体患者方面取得了成功,未发生感染暴发或耐药性出现。建议实施基于各个科室而非全院抗菌谱的控制性抗生素方案并进行定期评估。